Breast Screening Guideline Debates and CEM Advances
Key Questions
What are the main differences in breast screening guidelines between organizations?
ACP recommends biennial screening while ACS, NCCN, SBI, and ACR favor annual MRI and mammography for eligible women. Rising cancer rates in younger women fuel ongoing debates.
What did a 10-year study find about ultrasound after DBT screening?
It detected 1 additional cancer per 1000 women but had a 98.5% false-positive rate. Commentaries suggest shifting to MRI or CEM instead of routine supplemental ultrasound.
How cost-effective is contrast-enhanced mammography in low- and middle-income countries?
CEM costs about one-fifth of MRI while maintaining diagnostic utility, making it viable in settings like Pakistan. Programs in Snohomish County demonstrate scalable high-risk identification.
What role does BPE play as a risk marker on MRI?
RSNA studies show background parenchymal enhancement serves as an independent risk marker, particularly for Black women beyond breast density alone.
What cancer risk data exists for ATM variant carriers?
Heterozygotes face a hazard ratio of 4.0 with cumulative risk reaching 40% by age 80, informing risk-stratified surveillance guidelines.
Why are BRCA1 variants not predictive in Nigerian women according to studies?
Population-specific genomics research reveals BRCA1 variants lack the same predictive power seen in other groups, highlighting need for tailored genetic models.
How does multiparametric MRI aid breast cancer subtyping?
It distinguishes luminal from non-luminal invasive ductal carcinoma with an AUC of 0.92, supporting more precise treatment planning.
What patient guidance does Johns Hopkins provide on AI in screening?
The guide aligns with SBI/ACR recommendations, positioning AI as a reliable second reader to enhance mammography interpretation.
ACP biennial vs ACS/NCCN/SBI/ACR annual MRI; rising young women cancer rates. Large 10-year study confirms ultrasound after DBT yields 1 cancer/1000 with 98.5% false-positive rate; commentary calls for end to ultrasound supplemental screening, recommending MRI/CEM. CEM cost-effective in LMICs (Pakistan), 1/5th MRI cost. Snohomish County CEM program identifies 2,300 high-risk women. RSNA study shows BPE as risk marker beyond density for Black women. ASCO risk-stratified surveillance guidelines. ATM risk data (HR 4.0, cumulative 40% by 80). BRCA1 variants not predictive in Nigerian women. JAMA on guideline battle. Multiparametric MRI subtyping (AUC 0.92). ERN GENTURIS PTEN guideline. Podcast on guideline contradictions. Johns Hopkins patient guide aligns with SBI/ACR guidelines.